SVASTEK Secures ₹2 Crore Seed Funding to Revolutionize Respiratory and Critical Care
Boost for India’s MedTech Sector
Delhi-based medtech startup SVASTEK has raised ₹2 crore in seed funding, led by the IAN Angel Fund. This funding is set to accelerate the rollout of its flagship product, the ALLTIP-enabled NIV mask, while strengthening its distributor network, clinical application team, and outreach efforts across India.
Continue Exploring: The End of a Retail Era: Neville Noronha Checks Out, Anshul Asawa Checks In
Innovative Respiratory Solutions with ALLTIP Technology
Founded in 2022 by Arita Abrol, SVASTEK focuses on addressing critical gaps in respiratory and critical care. Its ALLTIP-enabled NIV mask combines noninvasive ventilation with simultaneous nutrition delivery, offering a unique solution for patients requiring long-term respiratory support. This innovation not only enhances patient care but also aims to reduce malnutrition risks commonly associated with respiratory illnesses.
Tapping into India’s ₹48,500 Crore Respiratory Market
With India’s respiratory and critical care market valued at ₹48,500 crore (approximately $5.8 billion) and growing at a CAGR of 8.3%, SVASTEK is strategically positioned to capitalize on this expanding sector. The startup plans to expand its reach across the country, introduce new products, and eventually enter global markets to make respiratory care more accessible and affordable.
Continue Exploring: NONSTOP launches first flagship store in Mumbai, offering mobility and wellness solutions
Founder’s Vision and Industry Impact
“We’re thrilled to have secured this funding—it’s more than just financial support; it validates our mission to create impactful and transformative solutions for the medtech industry,” said Arita Abrol, founder of SVASTEK. “This investment will help us expand our team, enhance innovation, and strengthen our position in a rapidly evolving sector. India’s medtech ecosystem is flourishing, with initiatives like MedTech Mitra, BIRAC grants, and Make in India paving the way for groundbreaking advancements.”
Future Outlook
SVASTEK’s innovative approach and focus on patient-centric solutions position it as a key player in India’s medtech sector. With ambitious plans to expand its product line and global footprint, the startup aims to redefine respiratory and critical care, ultimately contributing to a healthier, more sustainable future.
